DOI: 10.1128/AAC.00522-20
Article Information
PubMed
Published By
History
- Received March 23, 2020
- Returned for modification May 24, 2020
- Accepted May 31, 2020
- Published online July 22, 2020.
Copyright & Usage
Copyright © 2020 Begum et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (June 08, 2020).
- You are viewing the most recent version of this article.
Author Information
- Khurshida Beguma,
- Eugénie Bassèresa,
- Julie Mirandaa,
- Chris Lancastera,
- Anne J. Gonzales-Lunaa,
- Travis J. Carlsonb,
- Tasnuva Rashida,
- David W. Eyrec,d,
- Mark H. Wilcoxe,f,
- M. Jahangir Alama and
- Kevin W. Gareya
- aUniversity of Houston College of Pharmacy, Houston, Texas, USA
- bFred Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA
- cBig Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- dNational Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom
- eHealthcare Associated Infections Research Group, Leeds Institute for Medical Research, University of Leeds, Old Medical School, Leeds General Infirmary, Leeds, United Kingdom
- fMicrobiology, Leeds Teaching Hospitals NHS Trust, Old Medical School, Leeds General Infirmary, Leeds, United Kingdom
- Address correspondence to Kevin W. Garey, kgarey{at}uh.edu.
Citation Begum K, Bassères E, Miranda J, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Rashid T, Eyre DW, Wilcox MH, Alam MJ, Garey KW. 2020. In vitro activity of omadacycline, a new tetracycline analog, and comparators against Clostridioides difficile. Antimicrob Agents Chemother 64:e00522-20. https://doi.org/10.1128/AAC.00522-20.
